21Shares XRP ETF has taken a significant step by filing a prospectus supplement that includes its latest quarterly report. This filing, submitted on November 10, 2026, is crucial for maintaining transparency and regulatory compliance in the competitive exchange-traded fund (ETF) market.

The filing indicates that 21Shares XRP ETF is committed to keeping its investors informed and adhering to the necessary regulations. This is particularly important in the context of the cryptocurrency and digital asset markets, which are under increasing scrutiny from regulators.

Company Background

21Shares XRP ETF is classified under the SIC code 6221, which pertains to Commodity Contracts Brokers & Dealers. The company operates under the ticker symbol TOXR and is listed on the CBOE exchange. It is categorized as a non-accelerated filer, smaller reporting company, and an emerging growth company.

What the Filing Says

The prospectus supplement serves as an update to the Trust's previous disclosures, specifically the prospectus dated December 10, 2025. It states, "The purpose of this Supplement is to include the Trust’s Quarterly Report on Form 10-Q filed on November 10, 2026." This report provides essential financial information and insights into the Trust's performance.

Impact

This filing may affect various stakeholders, including current and potential investors who rely on accurate and timely information to make informed decisions. It also reflects the company's ongoing efforts to comply with regulatory requirements, which is vital for maintaining investor confidence in the ETF market.

What's Next

The filing does not say what happens next.